AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Clinical importance of cytogenetics in acute myeloid leukaemia
Authors: Mrozek, K Heinonen, K Bloomfield, CD
Citation: K. Mrozek et al., Clinical importance of cytogenetics in acute myeloid leukaemia, BEST P R C, 14(1), 2001, pp. 19-47
Spectral karyotyping reveals 17;22 fusions in a cytogenetically atypical dermatofibrosarcoma protuberans with a large marker chromosome as a sole abnormality
Authors: Mrozek, K Iliszko, M Rys, J Babinska, M Niezabitowski, A Bloomfield, CD Limon, J Babinska, M Niezabitowksi, A Bloomfield, CD Limon, J
Citation: K. Mrozek et al., Spectral karyotyping reveals 17;22 fusions in a cytogenetically atypical dermatofibrosarcoma protuberans with a large marker chromosome as a sole abnormality, GENE CHROM, 31(2), 2001, pp. 182-186
Quantification of CBF beta/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia
Authors: Marcucci, G Caligiuri, MA Dohner, H Archer, KJ Schlenk, RF Dohner, K Maghraby, EA Bloomfield, CD
Citation: G. Marcucci et al., Quantification of CBF beta/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia, LEUKEMIA, 15(7), 2001, pp. 1072-1080
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B study
Authors: Mrozek, K Prior, TW Edwards, C Marcucci, G Carroll, AJ Snyder, PJ Koduru, PRK Theil, KS Pettenati, MJ Archer, KJ Caligiuri, MA Vardiman, JW Kolitz, JE Larson, RA Bloomfield, CD
Citation: K. Mrozek et al., Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B study, J CL ONCOL, 19(9), 2001, pp. 2482-2492
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: Results of cancer and leukemia group B study 9251
Authors: Lee, EJ Petroni, GR Schiffer, CA Freter, CE Johnson, JL Barcos, M Frizzera, G Bloomfield, CD Peterson, BA
Citation: Ej. Lee et al., Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: Results of cancer and leukemia group B study 9251, J CL ONCOL, 19(20), 2001, pp. 4014-4022
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics
Authors: Virtaneva, K Wright, FA Tanner, SM Yuan, B Lemon, WJ Caligiuri, MA Bloomfield, CD de la Chapelle, A Krahe, R
Citation: K. Virtaneva et al., Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics, P NAS US, 98(3), 2001, pp. 1124-1129
BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia
Authors: Tanner, SM Austin, JL Leone, G Rush, LJ Plass, C Heinonen, K Mrozek, K Sill, H Knuutila, S Kolitz, JE Archer, KJ Caligiuri, MA Bloomfield, CD de la Chapelle, A
Citation: Sm. Tanner et al., BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia, P NAS US, 98(24), 2001, pp. 13901-13906
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study
Authors: Whitman, SP Archer, KJ Feng, L Baldus, C Becknell, B Carlson, BD Carroll, AJ Mrozek, K Vardiman, JW George, SL Kolitz, JE Larson, RA Bloomfield, CD Caligiuri, NA
Citation: Sp. Whitman et al., Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study, CANCER RES, 61(19), 2001, pp. 7233-7239
The partial nontandem duplication of the MLL (ALL1) gene is a novel rearrangement that generates three distinct fusion transcripts in B-cell acute lymphoblastic leukemia
Authors: Whitman, SP Strout, MP Marcucci, G Freud, AG Culley, LL Zeleznik-Le, NJ Mrozek, K Theil, KS Kees, UR Bloomfield, CD Caligiuri, MA
Citation: Sp. Whitman et al., The partial nontandem duplication of the MLL (ALL1) gene is a novel rearrangement that generates three distinct fusion transcripts in B-cell acute lymphoblastic leukemia, CANCER RES, 61(1), 2001, pp. 59-63
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
Authors: Stone, RM Berg, DT George, SL Dodge, RK Paciucci, PA Schulman, PP Lee, EJ Moore, JO Powell, BL Baer, MR Bloomfield, CD Schiffer, CA
Citation: Rm. Stone et al., Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine, BLOOD, 98(3), 2001, pp. 548-553
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)
Authors: Baer, MR Stewart, GC Dodge, RK Leget, G Sule, N Mrozek, K Schiffer, CA Powel, BL Kolitz, JE Moore, JO Stone, RM Davey, FR Carrol, AJ Larson, RA Bloomfield, CD
Citation: Mr. Baer et al., High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361), BLOOD, 97(11), 2001, pp. 3574-3580
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci
Authors: Rush, LJ Dai, ZY Smiraglia, DJ Gao, X Wright, FA Fruhwald, M Costello, JF Held, WA Yu, L Krahe, R Kolitz, JE Bloomfield, CD Caligiuri, MA Plass, C
Citation: Lj. Rush et al., Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci, BLOOD, 97(10), 2001, pp. 3226-3233
Recent genetic studies of adult patients with acute myeloid leukemia performed by the Cancer and Leukemia Group B
Authors: Byrd, JC Carroll, AJ Caligiuri, MA Larson, RA Bloomfield, CD
Citation: Jc. Byrd et al., Recent genetic studies of adult patients with acute myeloid leukemia performed by the Cancer and Leukemia Group B, HEMAT BLOOD, 40, 2001, pp. 449-456
All-trans-retinoic acid maintenance for acute promyelocytic leukemia
Authors: Tallman, MS Andersen, JW Schiffer, CA Appelbaum, FR Feusner, JH Ogden, A Shepherd, L Willman, C Bloomfield, CD Rowe, JM Wiernik, PH
Citation: Ms. Tallman et al., All-trans-retinoic acid maintenance for acute promyelocytic leukemia, HEMAT BLOOD, 40, 2001, pp. 565-569
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
Authors: Costello, JF Fruhwald, MC Smiraglia, DJ Rush, LJ Robertson, GP Gao, X Wright, FA Feramisco, JD Peltomaki, P Lang, JC Schuller, DE Yu, L Bloomfield, CD Caligiuri, MA Yates, A Nishikawa, R Huang, HJS Petrelli, NJ Zhang, XL O'Dorisio, MS Held, WA Cavenee, WK Plass, C
Citation: Jf. Costello et al., Aberrant CpG-island methylation has non-random and tumour-type-specific patterns, NAT GENET, 24(2), 2000, pp. 132-138
Prognostic value of cytogenetic findings in adults with acute myeloid leukemia
Authors: Mrozek, K Heinonen, K Bloomfield, CD
Citation: K. Mrozek et al., Prognostic value of cytogenetic findings in adults with acute myeloid leukemia, INT J HEMAT, 72(3), 2000, pp. 261-271
The World Health Organization classification of hematological malignanciesreport of the Clinical Advisory Committee Meeting, Airlie House, Virginia,November 1997
Authors: Harris, NL Jaffe, ES Diebold, J Flandrin, G Muller-Hermelink, HK Vardiman, J Lister, TA Bloomfield, CD
Citation: Nl. Harris et al., The World Health Organization classification of hematological malignanciesreport of the Clinical Advisory Committee Meeting, Airlie House, Virginia,November 1997, MOD PATHOL, 13(2), 2000, pp. 193-207
Molecular and clinical advances in core binding factor primary acute myeloid leukemia: A paradigm for translational research in malignant hematology
Authors: Marcucci, G Caligiuri, MA Bloomfield, CD
Citation: G. Marcucci et al., Molecular and clinical advances in core binding factor primary acute myeloid leukemia: A paradigm for translational research in malignant hematology, CANCER INV, 18(8), 2000, pp. 768-780
Problematic WHO reclassification of myelodysplastic syndromes - Reply
Authors: Bennett, JM Flandrin, G Matutes, E Bloomfield, CD Head, D Pierre, R Brunning, RD Imbert, M Vardiman, J
Citation: Jm. Bennett et al., Problematic WHO reclassification of myelodysplastic syndromes - Reply, J CL ONCOL, 18(19), 2000, pp. 3449-3451
Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: Evidence for its fusion with MLL in acute myeloid leukemia
Authors: Kourlas, PJ Strout, MP Becknell, B Veronese, ML Croce, CM Theil, KS Krahe, R Ruutu, T Knuutila, S Bloomfield, CD Caligiuri, MA
Citation: Pj. Kourlas et al., Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: Evidence for its fusion with MLL in acute myeloid leukemia, P NAS US, 97(5), 2000, pp. 2145-2150
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RAR alpha isoform: results from Intergroup protocol 0129
Authors: Slack, JL Willman, CL Andersen, JW Li, YP Viswanatha, DS Bloomfield, CD Tallman, MS Gallagher, RE
Citation: Jl. Slack et al., Molecular analysis and clinical outcome of adult APL patients with the type V PML-RAR alpha isoform: results from Intergroup protocol 0129, BLOOD, 95(2), 2000, pp. 398-403
Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene
Authors: Plass, C Yu, F Yu, L Strout, MP El-Rifai, W Elonen, E Knuutila, S Marcucci, G Young, DC Held, WA Bloomfield, CD Caligiuri, MA
Citation: C. Plass et al., Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene, ONCOGENE, 18(20), 1999, pp. 3159-3165
Core-binding factor (CBF) and MLL-associated primary acute myeloid leukemia: biology and clinical implications
Authors: Strout, MP Marcucci, G Caligiuri, MA Bloomfield, CD
Citation: Mp. Strout et al., Core-binding factor (CBF) and MLL-associated primary acute myeloid leukemia: biology and clinical implications, ANN HEMATOL, 78(6), 1999, pp. 251-264
The World Health Organization classification of neoplastic diseases of thehematopoietic and lymphoid tissues
Authors: Harris, NL Jaffe, ES Diebold, J Flandrin, G Muller-Hermelink, HK Vardiman, J Lister, TA Bloomfield, CD
Citation: Nl. Harris et al., The World Health Organization classification of neoplastic diseases of thehematopoietic and lymphoid tissues, ANN ONCOL, 10(12), 1999, pp. 1419-1432
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered
Authors: Byrd, JC Dodge, RK Carroll, A Baer, MR Edwards, C Stamberg, J Qumsiyeh, M Moore, JO Mayer, RJ Davey, F Schiffer, CA Bloomfield, CD
Citation: Jc. Byrd et al., Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered, J CL ONCOL, 17(12), 1999, pp. 3767-3775
Risultati: 1-25 | 26-31